SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-19-000135
Filing Date
2019-10-02
Accepted
2019-10-02 17:05:15
Documents
1
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157005026880224.html 4  
1 FORM 4 wf-form4_157005026880224.xml 4 5647
  Complete submission text file 0000920465-19-000135.txt   6984
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1960 KIRBY ROAD MCLEAN VA 22101
Business Address
Chawla Lakhmir S (Reporting) CIK: 0001646626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 191133091